ストックスクリーナーアプリを入手
13.32
0.60%
0.08
アフターアワーズ：
13.32
前日終値:
$13.24
開ける：
$13.2
24時間の取引高:
12.86M
Relative Volume:
1.05
時価総額：
$47.82B
収益：
$32.28B
当期純損益:
$6.67B
株価収益率:
7.816
EPS:
1.7042
ネットキャッシュフロー:
$210.02B
1週間 パフォーマンス:
+2.78%
1か月 パフォーマンス:
+5.63%
6か月 パフォーマンス:
+19.25%
1年 パフォーマンス:
+86.82%
1日の値動き範囲:
$13.15
$13.41
1週間の範囲:
$12.93
$13.41
52週間の値動き範囲:
$7.02
$13.57
Barclays Plc Adr Stock (BCS) Company Profile
BCS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| BCS | 13.32 | 47.82B | 32.28B | 6.67B | 210.02B | 1.7042 |
| JPM | 244.76 | 693.00B | 173.22B | 53.77B | -129.54B | 16.75 |
| BAC | 46.46 | 359.47B | 98.50B | 23.61B | -2.00B | 3.57 |
| WFC | 74.83 | 249.98B | 82.40B | 18.09B | 12.33B | 4.63 |
| RY | 125.09 | 176.26B | 44.14B | 11.92B | -5.90B | 6.2748 |
| HSBC | 46.32 | 167.20B | 68.15B | 23.60B | 153.10B | 6.95 |
Barclays Plc Adr Stock (BCS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-10-26 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-09-26 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-08-08 | ダウングレード | Exane BNP Paribas | Outperform → Neutral |
| 2023-05-12 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-12-14 | アップグレード | Exane BNP Paribas | Neutral → Outperform |
| 2022-12-06 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-04-22 | アップグレード | Citigroup | Neutral → Buy |
| 2022-03-29 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-01-28 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-12-07 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2021-09-30 | アップグレード | Redburn | Neutral → Buy |
| 2021-03-16 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-03-12 | アップグレード | Goldman | Neutral → Buy |
| 2020-11-10 | ダウングレード | Investec | Buy → Hold |
| 2020-07-10 | アップグレード | Investec | Hold → Buy |
| 2020-03-03 | ダウングレード | Societe Generale | Buy → Hold |
| 2020-02-11 | 再開されました | Credit Suisse | Neutral |
| 2019-11-26 | アップグレード | Exane BNP Paribas | Neutral → Outperform |
| 2019-09-05 | アップグレード | Keefe Bruyette | Underperform → Mkt Perform |
| 2019-08-21 | アップグレード | Exane BNP Paribas | Underperform → Neutral |
| 2019-04-18 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2018-10-01 | アップグレード | Berenberg | Hold → Buy |
| 2018-06-19 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2018-04-16 | アップグレード | Jefferies | Hold → Buy |
| 2018-03-29 | アップグレード | Investec | Hold → Buy |
| 2018-03-20 | ダウングレード | Investec | Buy → Hold |
| 2018-03-08 | アップグレード | Goldman | Sell → Neutral |
| 2018-01-11 | ダウングレード | Keefe Bruyette | Mkt Perform → Underperform |
| 2018-01-10 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2017-12-15 | ダウングレード | Investec | Buy → Hold |
| 2017-11-20 | アップグレード | BofA/Merrill | Underperform → Buy |
| 2017-10-31 | アップグレード | Keefe Bruyette | Underperform → Mkt Perform |
| 2017-10-20 | アップグレード | Berenberg | Sell → Hold |
すべてを表示
Barclays Plc Adr (BCS) 最新ニュース
Where the Money Is: September 23 - AOL
Major Improvements In Barclays plc ADR (BCS) Stock Need To Be Considered - Stocks Register
Arista Networks Stock: Is Wall Street Bullish Or Bearish? - Barchart
Deutsche Bank Lays Off More Than 100 Senior Bankers To Reduce Costs - Barchart
Are Wall Street Analysts Bullish On Halliburton Stock? - Barchart
Wells Fargo Stock: Analyst Estimates & Ratings - Barchart
Do Wall Street Analysts Like Fifth Third Bancorp Stock? - Barchart
Ligand Pharmaceuticals (NASDAQ:LGND) Given New $150.00 Price Target at Barclays - Defense World
Are Wall Street Analysts Predicting Altria Group Stock Will Climb Or Sink? - Barchart
Are Wall Street Analysts Bullish On Coca-Cola Stock? - Barchart
Barclays Buys Tesco's Retail Banking Business, Commences Partnership - MSN
Are Wall Street Analysts Predicting Aptiv Stock Will Climb Or Sink? - Barchart
Share price and calculator - Barclays
2 UK Banks Enter the Top 100 Stocks to Buy. Time to Buy? - Barchart
Barclays plc ADR (NYSE: BCS) – Analysts’ Opinion Is Improving - Stocks Register
Barclays: On Track For Super-Charged Shareholder Returns (BCS) - Seeking Alpha
Barclays Mulls Over Re-Entering Saudi Arabia After Decade-Long Absence - Barchart
Foreign Exchange Strategic Business Report 2024: Global Market to Reach $1.4 Trillion by 2030, Driven by Rising Popularity of Online Forex Trading Platforms - GlobeNewswire Inc.
Here’s Why Oracle Corp. (NYSE: ORCL) Is An Attractive Investment Right Now - Stocks Register
SoundHound AI Inc (NASDAQ: SOUN) Stock: Up 75.65% From Low, Just Wait - Stocks Register
Weekly Upgrades and Downgrades - InvestorPlace
Barclays on Track for Highest Close Since December 2015 — Data Talk - Morningstar
Barclays' Q3 Earnings Jump On Solid IB, Stock Up On Uptick In NII Target - Barchart
Barclays PLCForm 8.3Britvic plc - Vox Markets
Market Insights: Argo Blockchain Plc ADR (ARBK)’s Notable Gain of 2.65, Closing at 1.16 - The Dwinnex
Goldman lifts Barclays plc ADR [BCS] price estimate. Who else is bullish? - The DBT News
Barclays plc ADR (BCS) Stock: Navigating a Year of Volatility - The InvestChronicle
CVS Health Corp (CVS) receives an Overweight rating from Barclays - Knox Daily
Polestar Automotive Holding UK PLC ADR (PSNY) did well last session? - US Post News
Was anything negative for Adaptimmune Therapeutics Plc ADR (ADAP) stock last session? - US Post News
Stocks Showing Market Leadership: Barclays ADR Earns 92 RS Rating - Investor's Business Daily
Barclays ups Man Group stock rating on undervalued shares - Investing.com India
Investing in Allegion plc (ALLE) Is Getting More Attractive - Knox Daily
A Guide To The Risks Of Investing In Barclays plc ADR (BCS) - Knox Daily
Potential Price Increase for HSBC Holdings plc ADR (HSBC) After Recent Insider Activity - Knox Daily
Monitoring RELX Plc ADR (RELX) after recent insider movements - Knox Daily
Barclays upgrades Evolus Inc (EOLS) stock to an Overweight - Knox Daily
A company insider recently sold 12,190 shares of Vir Biotechnology Inc [VIR]. Should You also Consider to Sale? - Knox Daily
Checking in on Wipro Ltd. ADR (WIT) after recent insiders movement - Knox Daily
Clifford Chance advises on Meituan's US$2.5 billion bond issuance - Lawyer Monthly Magazine
South Africa Reverse Factoring Market Size & Outlook, 2030 - Grand View Research
Saudi Arabia Reverse Factoring Market Size & Outlook, 2030 - Grand View Research
Spain Reverse Factoring Market Size & Outlook, 2023-2030 - Grand View Research
The Significance of Moving Averages in Barclays plc ADR Inc. (BCS) Price Performance - The InvestChronicle
Technical analysis of Adaptimmune Therapeutics Plc ADR (ADAP) stock chart patterns - US Post News
Barclays analysts upgrades an Overweight rating for Omnicom Group, Inc. (OMC) - Knox Daily
Wells Fargo gives an Overweight recommendation for Verona Pharma Plc ADR (VRNA) - Knox Daily
Barclays initates Reinsurance Group Of America, Inc. (RGA) stock to an Overweight - Knox Daily
Recent Insider Activity Suggests Potential Gains for Mereo Biopharma Group Plc ADR (MREO) - Knox Daily
Barclays’s latest rating for DVA stock - Knox Daily
Goldman Sachs initiates Barclays stock with Buy rating, sees strong EPS growth ahead - Investing.com
Barclays Plc Adr (BCS) 財務データ
収益
当期純利益
現金流量
EPS
0.64%
0.07%
大文字化:
|
ボリューム (24 時間):